Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.13 (
protein kinase C
)
49,245
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have used GH3 cells permeabilized by electric field discharge to examine the effects of Ca2+ and
protein kinase C
activators (phorbol ester and diacylglycerol) on
prolactin
(
PRL
) release. Ca2+ was found to stimulate
PRL
release approximately 4 fold at 3 microM Ca2+ with a half-maximal response at approximately .5 microM estimated free Ca2+. 12-O-tetradecanoyl phorbol-13-acetate and 1-oleoyl-2-acetyl-sn-glycerol stimulated
PRL
release throughout a range of Ca2+ concentrations (1 nM -3 microM), but stimulation was greater at higher Ca2+ concentrations (.1 microM to 1 microM). Both agents decreased by 1.8 fold the apparent [Ca2+] at which half-maximal stimulation of secretion occurred. Quin 2 was used to measure the free [Ca2+] of intact and permeable cells;
PRL
secretion at a free [Ca2+] corresponding to resting cytoplasmic [Ca2+] was 10% of maximal, while secretion at the [Ca2+] corresponding to the Ca2+ spike induced by thyrotropin-releasing hormone was approximately 25% of maximal.
...
PMID:Prolactin secretion in permeable GH3 pituitary cells is stimulated by Ca2+ and protein kinase C activators. 316 2
Rat liver nuclei pure by enzymatic and electron microscope criteria contain
protein kinase C
(
PKC
) that can be activated several hundredfold within 3 min of addition of
prolactin
or phorbol 12-tetradecanoate 13-acetate. Rat
prolactin
stimulated
PKC
maximally at 10(-12) M, whereas ovine
prolactin
was maximally stimulatory at 10(-10) M. Activation was time and dose dependent, exhibited a biphasic pattern, and was blocked by anti-
prolactin
antiserum, by
PKC
inhibitors such as 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine (H-7) and sphingosine, and by cyclosporine. Moreover, the ability of
prolactin
to activate nuclear
PKC
was inhibited totally by a monoclonal antibody to the rat liver prolactin receptor, implicating a prolactin receptor-mediated activation process. Epidermal growth factor (EGF), a liver mitogen, caused a lesser but significant activation of nuclear
PKC
. However, EGF and suboptimal
prolactin
were synergistic. Human growth hormone, which has lactogenic properties, stimulated
PKC
activity, whereas nonlactogenic substances such as ovine growth hormone, insulin, dexamethasone, and 8-bromo-cAMP were inactive. That this may be a general mechanism for
prolactin
is suggested by the ability of
prolactin
to stimulate
PKC
140-fold in rat splenocyte nuclei. Prolactin has comitogenic properties in lymphocytes.
...
PMID:Rapid activation of protein kinase C in isolated rat liver nuclei by prolactin, a known hepatic mitogen. 318 50
One of the most rapid actions of
prolactin
in mouse mammary gland explants is the stimulation of ornithine decarboxylase (ODC) activity. Several
protein kinase C
activators including mezerein, dicaprin, diolein, and 1-oleoyl-2-acetyl-rac-glycerol were found to stimulate ODC activity as does
prolactin
. Both mezerein and the diglycerides produced nonadditive responses when tested with maximum stimulatory concentrations of
prolactin
. The results of these studies therefore provide further evidence that the
prolactin
stimulation of ODC activation in the mammary gland may involve an activation of
protein kinase C
.
...
PMID:Effects of mezerein and diglycerides on ornithine decarboxylase activity in mouse mammary gland explants. 335 91
Phorbol ester tumor promoters such as 12-O-tetradecanoylphorbol acetate (TPA) activate the calcium- and phospholipid-dependent
protein kinase C
and enhance three biological responses (
prolactin
release,
prolactin
synthesis, and cell stretching) in GH4C5 rat pituitary cells. We have examined several actions on GH4C5 cells of TPA and two other classes of
protein kinase C
activators, synthetic cell permeant dioleins and bryostatins isolated from the marine bryozoan Bugula neritina. Bryostatins 1 and 2 (B1 and B2, respectively) competed for [3H]phorbol 12,13-dibutyrate binding to the
protein kinase C
complex in intact cells nearly equipotently with TPA. B1 and B2, 1-oleoyl-2-acetylglycerol (OAG) and 1,2-dioctanoylglycerol (Di8) as well as TPA each activated partially purified
protein kinase C
from GH4C5 cells. B1, B2, and TPA each enhanced the acute release of
prolactin
from GH4C5 cells to a similar maximal extent. B1, B2, and TPA also enhanced
prolactin
synthesis. However, B1 and B2 were only partial agonists because they enhanced
prolactin
synthesis to a lesser maximal extent than did TPA and, given in combination, they reduced TPA-enhanced
prolactin
synthesis. OAG and Di8 stimulated
prolactin
release (to a lesser maximal extent than TPA) and did not stimulate
prolactin
synthesis. Pretreatment with OAG did not reduce TPA-stimulated
prolactin
release or synthesis. B2 and TPA induced cell stretching in GH4C5 cells, whereas B1, OAG, and Di8 induced little if any stretching. B1, but not B2, given in combination with TPA antagonized TPA-induced stretching but did not reduce thyrotropin-releasing hormone- or epidermal growth factor-induced stretching. We conclude that the bryostatins, phorbol esters, and dioleins bind to the same site on the
protein kinase C
complex to activate the enzyme, but they alter three biological responses in GH4C5 cells with selectivities and efficacies that differ. We propose that different activators of
protein kinase C
(such as bryostatins, dioleins, and phorbol esters) may elicit different cellular responses by altering the substrate specificity or activating multiple forms of the kinase.
...
PMID:Three activators of protein kinase C, bryostatins, dioleins, and phorbol esters, show differing specificities of action on GH4 pituitary cells. 346 27
The hormonal regulation of
protein kinase C
(
PKC
) induction over 3 to 14 days was investigated in the mouse mammary gland in vitro and in vivo. In intact mice, estradiol (1 microgram/mouse injected daily for 2 weeks) stimulated
PKC
activity 70%, while progesterone (1 mg/mouse injected daily) inhibited it by 30%. Prolactin, whose levels were elevated for 2 weeks by two pituitary isografts, had no effect. When mammary gland explants were cultured in insulin and cortisol, the further addition of estradiol (1 ng/ml), progesterone (1 microgram/ml), or
prolactin
(1 microgram/ml) did not alter
PKC
activity after 3 days. These data suggest the following conclusions: although previous studies have implicated
prolactin
in the transient, calcium-phospholipid activation of
PKC
, it does not appear to elevate total levels of this kinase over prolonged periods. In contrast, the sex steroids do appear to affect long-term levels of this kinase; furthermore, this latter effect may be indirect.
...
PMID:Hormonal regulation of protein kinase C in the mouse mammary gland. 354 Sep 71
Prolactin stimulates a hepatotrophic response similar to that caused by phorbol esters or partial hepatectomy in rats. Since phorbol esters, which activate
protein kinase C
, mimic
prolactin
action in liver, the relationship between
prolactin
administration and subsequent hepatic
protein kinase C
translocation was assessed. Prolactin administration rapidly stimulated a 4-fold elevation of membrane protein kinase C activity. The effect of
prolactin
on hepatic
protein kinase C
was specific for lactogenic hormones but could be duplicated by phorbol esters. Further, an increase in serum
prolactin
was demonstrated subsequent to partial hepatectomy and preceding hepatic
protein kinase C
translocation. Therefore, translocation of hepatic
protein kinase C
appears important for hepatic proliferation in response to
prolactin
administration and to partial hepatectomy.
...
PMID:Hepatic protein kinase C: translocation stimulated by prolactin and partial hepatectomy. 369 11
Activation of calcium-activated, phospholipid-dependent
protein kinase C
by diacylglycerol and phorbol esters has been shown to mediate release of hormones in many systems. To determine whether
protein kinase C
activation is also involved in the regulation of
prolactin
release from human decidua, we have examined the effects of various acylglycerols and phorbol esters on the synthesis and release of
prolactin
from cultured human decidual cells. sn-1,2-Dioctanoylglycerol (diC8), which is known to stimulate
protein kinase C
in other systems, inhibited
prolactin
release in a dose-dependent manner with maximal inhibition of 53.1% (P less than 0.01) at 100 microM. Diolein (100 microM), which also stimulates
protein kinase C
activity in some systems, inhibited
prolactin
release by 21.3% (P less than 0.05). Distearin and dipalmitin, which are much less effective in activating
protein kinase C
, and monopalmitin and tripalmitin, which do not activate
protein kinase C
, had no significant effect on
prolactin
release. Phorbol 12-myristate 13-acetate (PMA), phorbol 12,13-didecanoate, and 4 beta-phorbol 12,13-dibutyrate, which activate
protein kinase C
in other systems, also inhibited the release of
prolactin
, while the
protein kinase C
inactivate 4 alpha-phorbol-12,13-didecanoate was without effect. The inhibition of
prolactin
release was secondary to a decrease in
prolactin
synthesis. The amounts of
prolactin
synthesized by cells exposed to diC8 (300 microM) or PMA (10(-7) M) for 30 min were 56.3 and 50.0% less than that synthesized by control cells (P less than 0.01 in each instance).(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Activation of protein kinase C inhibits synthesis and release of decidual prolactin. 374 Feb 56
The polypeptide thyrotropin-releasing hormone (TRH) and epidermal growth factor (EGF) stimulate, within seconds to minutes, the transcription of the
prolactin
gene in a rat pituitary cell line (GH4). Because a series of agents that act to stimulate
prolactin
secretion fail to alter
prolactin
gene transcription, it is suggested that secretory events are neither obligatory for nor causal of hormone-induced transcriptional stimulation. Elevation of cytosolic-free calcium does not stimulate
prolactin
gene transcription; however, several agents that act to antagonize calcium-dependent processes inhibit or abolish both TRH and EGF stimulation of
prolactin
gene transcription and a specific hormone-dependent nuclear phosphorylation. In contrast, inhibitors of the slow calcium channel exert minimal effects on TRH-stimulated
prolactin
gene expression, suggesting that calcium influx through membrane channels is not crucial for the observed nuclear actions of TRH. Activation of
protein kinase C
by phorbol esters mimics the nuclear actions of TRH. In the presence of increased intracellular calcium levels, the effects of 12-O-tetradecanoyl phorbol 13-acetate on
prolactin
gene transcription are quantitatively identical to those observed in response to TRH or EGF.
...
PMID:Molecular mechanisms of phorbol ester, thyrotropin-releasing hormone, and growth factor stimulation of prolactin gene transcription. 393 Apr 85
The effect of phorbol diester tumour promoters on the release of growth hormone (GH) and
prolactin
(Prl) was studied in rat pituitary cells cultured in monolayer. 12-O-tetradecanoyl phorbol-13-acetate (TPA), the most potent phorbol ester, stimulated GH accumulation in the cultured medium in a dose-dependent manner. TPA also stimulated Prl accumulation. A time course study indicated that TPA mainly stimulates release of GH. The maximal stimulation of GH release by TPA (100 ng/ml) was 3-4-fold over control. Phorbol-12,13-dibutyrate (PDB), another tumour-promoting phorbol ester, stimulated GH release to an extent similar to that of TPA, while a biologically inactive compound, phorbol-12,13-diacetate (PDA), had no effect. TPA-stimulated GH release was not affected by the presence of indomethacin, an inhibitor of prostaglandin (PG) synthesis, indicating that PG is not involved in the process of TPA-stimulated GH release. Co++, a competitive antagonist of Ca++, at 2.0 mM completely suppressed the GH release induced by TPA, and this inhibition was partially reversed by the addition of 2.0 mM Ca++. Verapamil, a Ca++ channel blocker, reduced TPA-stimulated GH release, and trifluoperazine, an inhibitor of Ca-calmodulin formation, had a similar effect. Somatostatin (SRIF) also inhibited the GH release by TPA. These observations are compatible with the idea that Ca++ may be involved in the process of TPA-stimulated GH release. Since TPA has been reported to activate a Ca++- and phospholipid-dependent protein kinase (
protein kinase C
), it is possible that TPA stimulate GH release by activating the enzyme. Further studies are required to clarify this point.
...
PMID:Effect of phorbol esters on the release of growth hormone and prolactin from rat pituitary cells cultured in monolayer. 614 63
Thyrotropin-releasing hormone (TRH) is a tripeptide that rapidly enhances
prolactin
secretion in clonal, hormone-responsive GH3 rat pituitary cells. In an effort to identify postreceptor mechanisms for TRH, protein phosphorylation studies have been conducted. Our previous studies (Drust, D.S., Sutton, C.A., and Martin, T. F. J. (1982) J. Biol. Chem. 257, 3306-3312; Drust, D.S., and Martin, T. F. J. (1982) J. Biol. Chem. 257, 7566-7573) showed that TRH rapidly (less than 15 s) increased the phosphorylation of at least six cytosolic proteins (41K (Mr = 41,000), several 59K, 65K, 82K, and 97K) and, with a 5- to 10-min latency, increased the phosphorylation of a seventh (80K). Cyclic AMP did not appear to mediate TRH-stimulation of protein phosphorylation; in contrast, Ca2+ translocation and Ca2+-dependent protein phosphorylation accounted for hormone-induced changes in 97K (and possibly 41K) phosphorylation. The studies reported here indicate that lipid (diacylglycerol) accumulation and
protein kinase C
activation mediate TRH-stimulated phosphorylation of the additional five cytosolic proteins (two 59K, 65K, 80K, and 82K). This conclusion is based on the findings that: 1) phospholipase C treatment, which produces diacylglycerol, mimicked several TRH effects; 2) bombesin, another peptide that induces inositol phosphatide turnover, mimicked several TRH effects; 3) phorbol esters, which were shown to activate GH3 cell
protein kinase C
directly, produced TRH-like effects; 4) partially purified GH3 cell cytosolic
protein kinase C
was activated by diacylglycerol; and 5) 59K and 82K proteins were endogenous in vitro substrates for a cytosolic lipid-stimulated protein kinase. We conclude that rapid TRH effects in promoting inositol phosphatide turnover in GH3 cells may be linked to the activation of protein phosphorylation mediated by
protein kinase C
. These, and previously reported studies, indicate a role for Ca2+ and lipids (diacylglycerol) as dual intracellular messengers for TRH.
...
PMID:Thyrotropin-releasing hormone rapidly activates protein phosphorylation in GH3 pituitary cells by a lipid-linked, protein kinase C-mediated pathway. 623 63
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>